Dr. Jonasch on Alternative Sunitinib Scheduling for mRCC

Sunitinib 4/2 vs 2/1 Schedule for Patients with mRCC

ASCO: Two-Year Survival Seen with Sutent in Kidney Cancer

Dr. George on Sunitinib in RCC

Sunitinib with or without surgery for metastatic renal cell carcinoma

Dosing Schedule of Sunitinib in Renal Cell Carcinoma

Dr. Figlin on Sunitinib for Patients With RCC

Dr. Hsieh Discusses Frontline Treatment of Kidney Cancer With Pazopanib and Sunitinib

Sunitinib Therapy at Progression of Metastatic GIST

Dr. Lara on the Role of Sunitinib for Renal Cell Carcinoma

Adjuvant Sunitinib’s Role in the Treatment of RCC

Adjuvant Sunitinib for High Risk Renal Cell Carcinoma: Not Ready for Prime Time

Frontline Sunitinib Compared to Everolimus in Metastatic Renal Cell Carcinoma

Dr. George on the Use of Adjuvant Sunitinib in RCC

Dr. Robert Dreicer on an Alternate Sunitinib Schedule in Metastatic Renal Cell Carcinoma

Examining Kidney Toxicities of Sunitinib and Imatinib in Long Term GIST Therapy

Progression of Metastatic GIST

Dr. Molina Talks About Pazopanib, Sunitinib and Other Recent Clinical Trials

Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma

Dr. Tannir on the Combination of Sunitinib and Temsirolimus for Metastatic Renal Cell Carcinoma